Comparative Prospective Detection of Recurrences of Carcinomas with SPECT Imaging Using Radiolabeled Monoclonal Antibodies, Ultrasonography and Computed Tomography
Generally, when there is a recurrence after initial treatment of a carcinoma, prognosis is poor because of the limited efficacy of the different therapeutic alternatives. The diagnosis is often too late to allow complete surgical resection, and chemotherapy, whether associated with radiotherapy or not, has then only a transient palliative effect. It is thus important to make the diagnosis of recurrence earlier, before clinical signs appear, in the hope of providing complete surgical resection.
KeywordsSPECT Imaging Tumor Uptake Complete Surgical Resection Antigenic Site Sulfur Colloid
Unable to display preview. Download preview PDF.
- 3.D. E. Brenner, M. I. Shaff, H. W. Jones, W. W. Grosh, F. A. Greco, L. S. Burnett, Abdominopelvic computed tomography: evaluation in patients undergoing second-look laparotomy for ovarian carcinoma, Obstet. Gyneacol. 65:715 (1985).Google Scholar
- 6.J. Y. Douillard, P. A. Lehur, G. Aillet, M. Kremer, A. Bianco-Arco, P. Peltier and J. F. Chatal, Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with GI tract tumor specificity, Cancer Research (1986) (in press).Google Scholar
- 7.B. A. Rhodes, D. J. Burke, K. Breslow, K. Reed, R. Austin, S. W. Burchiel, Effects of circulating antigen on antibody localization in vivo, in: “Radioimmunoassay and Radioimmunotherapy, ” S. W. Burchiel and B. A. Rhodes, eds., Elsevier Science Publishing Co., New York, pp. 26–39 (1983).Google Scholar
- 9.B. Delaloye, A. Bischof-Delaloye, F. Buchegger, V. Von Fliedner, J. P. Grob, J. C. Volant, J. Pettavel, J. P. Mach, Detection of colorectal carcinoma by emissioncomputerized tomography after injection of I-123-labeled Fab or F(ab’)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies, J. Clin. Invest. 77:301 (1986).PubMedCrossRefGoogle Scholar
- 10.C. Mainguene, G. Aillet, M. Kremer, J. F. Chatal, Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications, J. Nucl. Med. All. Sci. 30:19 (1986).Google Scholar
- 12.M. Granowska, J. Shepherd, K. E. Britton, B. Ward, S. Mather, J. Taylor-Papadimitriou, A. A. Epenetos, M. J. Carroll, C. C. Nimmon, L. A. Hawkins, M. Slevin, W. Flatman, T. Home, J. Burchell, H. Durbin, and W. Bodmer, Ovarian cancer: diagnosis using I-123 monoclonal antibody in comparison with surgical findings, Nucl. Med. Commun. 5:485 (1984).PubMedCrossRefGoogle Scholar
- 13.S. E. Halpern, P. L. Hagan, P. R. Garver, J. A. Koziol, A. W. N. Chen, J. M. Frincke, R. M. Bartholomew, G. S. David, and T. H. Adams, Stability, characterization and kinetics of In-111-labeled monoclonal anti-tumor antibodies in normal animals and nude mouse-human tumor models, Cancer Res. 43:5347 (1983).PubMedGoogle Scholar